Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
The Temple Comprehensive HIV Program provides multidisciplinary primary and HIV specialty care for over 1,100 patients.
If you need HIV testing, are newly diagnosed or want to transfer care to our clinic, please call 215-707-2401 to schedule an intake appointment.
We also provide evaluation and treatment for co-infection with HIV and chronic hepatitis C.
The Temple HIV Program, a Ryan White Title 1 grantee, can assist with specialized medication assistance, rapid HIV testing and STD screening and treatment. We also have preventative services such as PrEP (Pre-exposure Prophylaxis). The program recently added telemedicine HIV services with the Department of Corrections in Pennsylvania.
The program serves traditionally underrepresented minorities and women in a practice setting, fully integrated into the ambulatory medical offices. We do accept patients that do not have insurance. We have bilingual staff who speak Spanish. If you need HIV testing, are newly diagnosed or wanting to transfer care to our clinic, please call 215-707-2401 to schedule an intake appointment.
The Temple Comprehensive HIV Program has been involved in research trials and activities since 1990. We participated in some of the early NIH-sponsored trials to prevent mother-to-child transmission and community based research.
We have been involved in the Division of AIDS Clinical Trials Network since 1994 as a unit in INSIGHT (International Network for Strategic Initiatives in Global HIV Trials). Since 1998, we have been part of the Centers for Disease Control and Prevention and Cerner HIV Outpatient Study (HOPS), a dynamic observational database that tracks clinical trends and outcomes in multiple centers across the United States.
We participate in multiple investigator-initiated and pharmaceutical-sponsored trials.
